Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-12
2005-07-12
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S226800, C544S006000, C544S055000
Reexamination Certificate
active
06916806
ABSTRACT:
A compound of the formula (I) having a binding activity to the cannabinoid type 2 receptor:wherein R1is optionally substituted heterocyclic group or the like; R2and R2each is independently hydrogen or the like; m is an integer of 0 to 2; A is optionally substituted aromatic carbocyclic group or the like.
REFERENCES:
patent: 4681874 (1987-07-01), Hayase et al.
patent: 4931444 (1990-06-01), Van Wauwe et al.
patent: 5194434 (1993-03-01), Chiou
patent: 5433829 (1995-07-01), Pool et al.
patent: 6017919 (2000-01-01), Inaba et al.
patent: 6545050 (2003-04-01), Mittendorf et al.
patent: 1 219 612 (2002-07-01), None
patent: 62-29594 (1987-02-01), None
patent: 62-120374 (1987-06-01), None
patent: 98/41519 (1998-09-01), None
patent: 99/02499 (1999-01-01), None
patent: 00/42031 (2000-07-01), None
patent: 01/19807 (2001-03-01), None
T. Zawisza et al., “Synthesis and Pharmacological Analysis of New Derivatives of Tetrahydro-[1,3]-Thiazine and 2-Thiobarbituric Acid”, Arch. Immunol. Ther. Exp., vol. 29, No. 2, pp. 235-248, 1981.
J. Gieldanowski et al., “Pharmacological Activity in the Group of New Substituted Thiazoloacetic and Thiazinocarboxyl Acid Derivatives”, Arch. Immunol. Ther. Exp., vol. 26, No. 1-6, pp. 921-929, 1978.
K. Soderstrom et al., “Behavioral, Pharmacological, and Molecular Characterization of an Amphibian Cannabinoid Receptor”, Journal of Neurochemistry, vol. 75, No. 1, pp. 413-423, 2000.
K. Lake et al., “Cardiovascular Effects of Anadamide in Anesthetized and Conscious Normotensive and Hypertensive Rats”, Hypertension, vol. 29, pp. 1204-1210, 1997.
S. Munro et al., “Molecular Characterization of a Peripheral Receptor for Cannabinoids”, Letters to Nature, vol. 365, pp. 61-65, Sep. 2, 1993.
H. Iwamura et al., “In Vitro and in Vivo Pharmacological Characterization of JTE-907, A Novel Selective Ligand for Cannabinoid CB2Receptor”, J. Pharmacol. Exp. Ther., vol. 296, No. 2, pp. 420-425, 2001.
Kai Hiroyuki
Murashi Takami
Tomida Minoru
Berch Mark L
Habte Kahsay
Shionogi & Co. Ltd.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Medicinal composition containing 1,3-thiazine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal composition containing 1,3-thiazine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal composition containing 1,3-thiazine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3404832